Nov 22, 2022 10:01 AM (GMT+8) · EqualOcean
UB biotechnology (Zhejiang) Co., LTD. (Chinese：泛肽生物科技（浙江）有限公司) recently announced its completion of a Series A round of financing worth tens of millions of CNY. This round was invested by Yuanbio Venture Capital (Chinese：元生创投), with Potential Capital (Chinese：取势资本) acting as the exclusive financial advisor. The funds will be primarily used for further R&D and market expansion in the flow cytometry technology platform, providing comprehensive solutions for accurate assessment of immune function for clinical patients.

Source: